Authors
Latest:
Melphalan Flufenamide for Relapsed or Refractory Multiple MyelomaMelphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
Latest:
Thriving in a Digital World: Marketing Strategies for Independent PharmaciesCut through the online noise with these digital marketing tips for your independent pharmacy.
Latest:
Cannabinoid Hyperemesis Syndrome: Diagnosis and ManagementA deep dive for pharmacists into this frequently debilitating disorder
Latest:
Best Practices on Discussing Birth Control for AdolescentsThere are numerous methods of contraception available for adolescents.
Latest:
The Evolution of PharmacogenomicsPharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.
Latest:
Symptom Scoring Framework Helps Formalize Definition of Long COVIDFinalizing a definition for postacute sequelae of SARS-CoV-2 infection will lead to high-quality care and treatment for patients suffering from the condition.
Latest:
National Pharmacy Chain Opioid Settlements Poised to Affect Independent PharmaciesStipulations of the settlements include data reporting, annual training, and an independent compliance officer.
Latest:
Understanding What Vaccines Could Mean for Long COVIDResearch suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.
Latest:
Probiotics for the Prevention of Pediatric Antibiotic-Associated DiarrheaEvidence of the relationship between probiotics and antibiotics is lacking.
Latest:
FDA Approves Scoliosis Treatment For Young PatientsThe REFLECT Scoliosis Correction System from Globus Medical is intended to correct progressive scoliosis in pediatric patients while simultaneously maintaining stability and motion as well as allowing for future modulated growth.
Latest:
Independent Pharmacy: A Year in Review & Insights from AbroadLearn how the challenges and opportunities of the last year have impacted independent pharmacy professionals around the world.
Latest:
Morning RX: June 5, 2023Mandy Cohen is set to become the next CDC director, Medicare will cover a new class of Alzheimer’s drugs, and the WHO announces a landmark digital health initiative.
Latest:
FDA: CBD Requires Separate Regulatory Pathway from Dietary Supplements, FoodThe agency intends to work with Congress to create a pathway that balances the desire for access with regulatory oversight and risk management.
Latest:
Pediatric Vaccines Strongly Recommended, Study ShowsNot every vaccine is required, some are just strongly recommended. Here's what to know about 5 recommended vaccines.
Latest:
Metformin and Doxycycline Found Equally Effective in Treatment of AcneAlthough both drugs led to a reduction in severity, doxycycline was more efficacious in reducing inflammatory lesions.
Latest:
College Students and Misuse of SubstancesThe prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.
Latest:
Insomnia and Bipolar Disorder: New DirectionsThe average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.
Latest:
Improve Patient Care and Chronic Disease ManagementHealthcare professionals need to make patients the primary decision-makers in their own care and actively support their efforts to achieve their care goals.
Latest:
The Good, The Bad, and the Missed Opportunity of Mark Cuban Cost Plus Drug CompanyThe billionaire’s first venture into pharmacy launched earlier this year.
Latest:
Breast Cancer Detection Drug Up For FDA ApprovalThe drug, called Lumisight, is an optical imaging agent that detects cancerous tissue during initial lumpectomy to allow for a more complete resection. An NDA has been submitted to the FDA.
Latest:
Why Patient Education Is More Important Than EverHow pharmacists can address knowledge gaps and health literacy challenges to help people with chronic conditions stay adherent to drug therapies
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Latest:
Investigators Publish Metric for Recommending Low-dose Aspirin ProphylaxisThe atrial fibrillation drug, asundexian, may provide protection from thrombotic events without a corresponding increase in bleeding risk.
Latest:
Bempedoic Acid for HypercholesterolemiaAn expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Latest:
Hospital Pharmacies and Budget Management: How Technology Can HelpThe hospital pharmacy must play its part by leveraging technology to control the costs of doing business and supporting the enterprise in addition to focusing on patient care.
Latest:
New Advances in Breast Cancer TherapyBreast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.
Latest:
Senate Finance Committee Urges PBMs To Make Big ChangesMembers of the Senate Finance Committee are pushing PBMs to modernize the rules regarding out of pocket costs and competition.
Latest:
COVID-19 National Emergencies to End in MayThe public health emergency, which was set to end April 11, and the national emergency, which was set to end March 1, will be ended on May 11 by the Biden administration.
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
